SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-049361
Filing Date
2017-02-21
Accepted
2017-02-21 07:27:32
Documents
3
Period of Report
2017-02-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d354714d8k.htm 8-K 14343
2 EX-99.1 d354714dex991.htm EX-99.1 8011
3 GRAPHIC g354714g86z83.jpg GRAPHIC 3768
  Complete submission text file 0001193125-17-049361.txt   29107
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 17623466
SIC: 2834 Pharmaceutical Preparations